Proposal for risk control of thoracic surgery during the COVID-19 pandemic_Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Authors：

LI Hui ¹ ,  YOU Bin ¹ , OU Songlei ² , LIU Lunxu ³ , LI Xiaofei ⁴ , ZHANG Lanjun ⁵ , CHEN Keneng ⁶ ,  JIANG Gening ⁷

1. Department of Thoracic Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing, 100020, P. R. China;
2. Department of Thoracic Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100020, P. R. China;
3. Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, 610041, P. R. China;
4. Department of Thoracic Surgery, Xi'an International Medical Center Hospital, Xi'an, 710117, P. R. China;
5. Department of Thoracic Surgery, Sun Yat-sen University Cancer Hospital, Guangzhou, 510062, P. R. China;
6. Department of Thoracic Surgery, Peking University Cancer Hospital, Beijing, 100143, P. R. China;
7. Department of Thoracic Surgery, Shanghai Lung Hospital, Tongji University, Shanghai, 200433, P. R. China;

Corresponding author：

YOU Bin, Email: yb2759@sina.com; JIANG Gening, Email: jgnwp@aliyun.com

Keywords：

Coronavirus disease 2019; thoracic surgery; decision-making

DOI：

10.7507/1007-4848.202301010

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

With the change of coronavirus disease 2019 (COVID-19) prevention and control strategy in China, the number of COVID-19 cases has increased significantly recently, which has also brought new challenges to the perioperative risk control of thoracic surgery. This paper puts forward several suggestions, aiming to standardize the preoperative screening and evaluation during the COVID-19 period, strictly grasp the indications and timing of surgery, optimize the medical management process, individualize surgical decision-making, and minimize the risk of COVID-19 infection to surgery.

Citation： LI Hui, YOU Bin, OU Songlei, LIU Lunxu, LI Xiaofei, ZHANG Lanjun, CHEN Keneng, JIANG Gening. Proposal for risk control of thoracic surgery during the COVID-19 pandemic. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2023, 30(2): 159-161. doi: 10.7507/1007-4848.202301010 Copy

1.	Sato Y, Yamamoto H, Ikeda N, et al. The impact of COVID-19 on thoracic surgical procedures in Japan: Analysis of data from the National Clinical Database. Lung Cancer, 2022, 172: 127-135.
2.	Shao CC, McLeod MC, Thogaripally S, et al. Increased risk of postoperative mortality associated with prior COVID-19 infection. Am J Prev Med, 2022, 63(1 Suppl 1): S75-S82.75-82.
3.	Yilmaz S, Sapci I, Jia X, et al. Risk factors associated with postoperative mortality among COVID-19 positive patients: Results of 3027 operations and procedures. Ann Surg, 2022, 276(6): 969-974.
4.	Dziodzio T, Knitter S, Wu HH, et al. Thoracic surgery in the COVID-19 pandemic: A novel spproach to teach guideline consensus. J Clin Med, 2021, 10(13): 2769.
5.	Passaro A, Addeo A, Von Garnier C, et al. ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer. ESMO Open, 2020, 5(Suppl 3): e000820.
6.	Kapetanakis EI, Tomos IP,. Karakatsani A,. , et al. , Management of surgical lung cancer patients during the COVID-19 pandemic in the financially and resource strained Greek health care system. J Surg Oncol, 2020, 122(2): 124-127.
7.	Şentürk M, El Tahan MR, Shelley B, et al. Thoracic Anesthesia during the COVID-19 Pandemic: 2021 Updated Recommendations by the European Association of Cardiothoracic Anaesthesiology and Intensive Care (EACTAIC) Thoracic Subspecialty Committee. J Cardiothorac Vasc Anesth, 2021, 35(12): 3528-3546.
8.	Li X, Liu M, Zhao Q, et al. Preliminary recommendations for lung surgery during COVID-19 epidemic period. Thorac Cancer, 2020, 11(6): 1372-1374.
9.	Chen KN, Gao S, Liu L, et al. Thoracic surgeons' insights: improving thoracic surgery outcomes during the coronavirus disease 2019 pandemic. Ann Thorac Surg, 2020, 110(2): 349-352.
10.	Thoracic Surgery Outcomes Research Network Inc, Antonoff M, Backhus L, et al. COVID-19 guidance for triage of operations for thoracic malignancies: A consensus statement from Thoracic Surgery Outcomes Research Network. J Thorac Cardiovasc Surg, 2020, 160(2): 601-605.
11.	Merritt RE, Kneuertz PJ. Considerations for the surgical management of early dtage lung cancer during the COVID-19 Pandemic. Clin Lung Cancer, 2021, 22(3): 156-160.
12.	Hoyos Mejía L, Romero Román A, Gil Barturen M, et al. Thoracic surgery during the coronavirus disease 2019 (COVID-19) pandemic in Madrid, Spain: Single-centre report. Eur J Cardiothorac Surg, 2020, 58(5): 991-996.
13.	Maurizi G, Rendina EA. A high-volume thoracic durgery fivision into the dtorm of the COVID-19 pandemic. Ann Thorac Surg, 2020, 110(2): 353-354.

1. Sato Y, Yamamoto H, Ikeda N, et al. The impact of COVID-19 on thoracic surgical procedures in Japan: Analysis of data from the National Clinical Database. Lung Cancer, 2022, 172: 127-135.
2. Shao CC, McLeod MC, Thogaripally S, et al. Increased risk of postoperative mortality associated with prior COVID-19 infection. Am J Prev Med, 2022, 63(1 Suppl 1): S75-S82.75-82.
3. Yilmaz S, Sapci I, Jia X, et al. Risk factors associated with postoperative mortality among COVID-19 positive patients: Results of 3027 operations and procedures. Ann Surg, 2022, 276(6): 969-974.
4. Dziodzio T, Knitter S, Wu HH, et al. Thoracic surgery in the COVID-19 pandemic: A novel spproach to teach guideline consensus. J Clin Med, 2021, 10(13): 2769.
5. Passaro A, Addeo A, Von Garnier C, et al. ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer. ESMO Open, 2020, 5(Suppl 3): e000820.
6. Kapetanakis EI, Tomos IP,. Karakatsani A,. , et al. , Management of surgical lung cancer patients during the COVID-19 pandemic in the financially and resource strained Greek health care system. J Surg Oncol, 2020, 122(2): 124-127.
7. Şentürk M, El Tahan MR, Shelley B, et al. Thoracic Anesthesia during the COVID-19 Pandemic: 2021 Updated Recommendations by the European Association of Cardiothoracic Anaesthesiology and Intensive Care (EACTAIC) Thoracic Subspecialty Committee. J Cardiothorac Vasc Anesth, 2021, 35(12): 3528-3546.
8. Li X, Liu M, Zhao Q, et al. Preliminary recommendations for lung surgery during COVID-19 epidemic period. Thorac Cancer, 2020, 11(6): 1372-1374.
9. Chen KN, Gao S, Liu L, et al. Thoracic surgeons' insights: improving thoracic surgery outcomes during the coronavirus disease 2019 pandemic. Ann Thorac Surg, 2020, 110(2): 349-352.
10. Thoracic Surgery Outcomes Research Network Inc, Antonoff M, Backhus L, et al. COVID-19 guidance for triage of operations for thoracic malignancies: A consensus statement from Thoracic Surgery Outcomes Research Network. J Thorac Cardiovasc Surg, 2020, 160(2): 601-605.
11. Merritt RE, Kneuertz PJ. Considerations for the surgical management of early dtage lung cancer during the COVID-19 Pandemic. Clin Lung Cancer, 2021, 22(3): 156-160.
12. Hoyos Mejía L, Romero Román A, Gil Barturen M, et al. Thoracic surgery during the coronavirus disease 2019 (COVID-19) pandemic in Madrid, Spain: Single-centre report. Eur J Cardiothorac Surg, 2020, 58(5): 991-996.
13. Maurizi G, Rendina EA. A high-volume thoracic durgery fivision into the dtorm of the COVID-19 pandemic. Ann Thorac Surg, 2020, 110(2): 353-354.

Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Proposal for risk control of thoracic surgery during the COVID-19 pandemic

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content